Inventor · disambiguated record
Marc C. Torjman
Also filed as: TORJMAN MARC C
2 granted patents·3 pending applications·39 citations·filing 2012–2025
66Inventor score
Top patents by PatentIndex Score
5 records- 0192US9867830B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2016·Granted Jan 16, 2018·12 cites·11 claims
- 0292US9650352B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painCOOPER HEALTH SYSTEM·Filed 2012·Granted May 16, 2017·27 cites·22 claims
- 0377US2025319092A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 0468US2020360393A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 0559US2018098993A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc C. Torjman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →